Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Cancer Organoids × Anastrozole × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 211 Neoplasm Metastasis 15 Neoplasms 14 Carcinoma, Intraductal, Noninfiltrating 9 Advanced Breast Cancer 7 Breast Neoplasms, Male 6 Breast Diseases 6 Breast Carcinoma In Situ 5 Triple Negative Breast Neoplasms 4 Ovarian Neoplasms 4 Endometrial Neoplasms 4 Arthralgia 4 Neoplasms by Site 3 Breast Cancer Metastatic 3 Recurrence 2 Osteoporosis 2 Obesity 2 Multiple Endocrine Neoplasia Type 1 2 Carcinoma, Non-Small-Cell Lung 2 Vitamin D Deficiency 1 Uterine Cervical Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Solid Tumor 1 Skin Diseases 1 Sexual Dysfunction, Physiological 1 Seizures 1 Sarcoma 1 Quality of Life 1 Prostatic Neoplasms 1 Patient Compliance 1

Interventions

pyrrolidine 1 pirarubicin 1 olaparib 1 ixabepilone 1 exemestane 1 eribulin 1 apatinib 1 Vinorelbine 1 Trastuzumab 1 Toremifene 1 Tamoxifen 1 Paclitaxel 1 Methotrexate 1 Letrozole 1 Gemcitabine 1 Fulvestrant 1 Fluorouracil 1 Epirubicin 1 Endostatins 1 Doxorubicin 1 Cyclophosphamide 1 Cisplatin 1 Carboplatin 1 Capecitabine 1 Bevacizumab 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03925233 2019-04-24

Breast Cancer Treatment Based on Organ-like Culture

Xijing Hospital

Breast Cancer Organoids

Data powered by HemOnc (CC BY 4.0) Colophon ⚡